Abstract
The effects of human urotensin II (hUII) on the vascular tone of different animal species has been studied extensively. However, little has been reported on the vasoactive effects of rat urotensin (rUII) in murine models. The aim of the present study was to investigate the effects of rUII on vasoreactivity in rat basilar arteries. Basilar arteries from adult male Wistar rats (300–350 g) were isolated, cut in rings, and mounted on a small vessel myograph to measure isometric tension. rUII concentrations were studied in both resting and depolarized state. To remove endothelial nitric oxide effects from the rUII response, we treated selected arterial rings with Nω-nitro-L-arginine methyl ester (L-NAME). 10 μM rUII produced a potent vasoconstrictor response in rat basilar arteries with intact endothelium, while isometric forces remained unaffected in arterial rings treated with lower rUII concentrations. Although L-NAME did not have a significant effect on 10 μM rUII-evoked contraction, it slightly increased arterial ring contraction elicited by 1 μM rUII. In depolarized arteries, dose-dependent rUII increased depolarization-induced contractions. This effect was suppressed by L-NAME. Our results show that the rat basilar artery has a vasoconstrictor response to rUII. The most potent vasoconstrictor effect was produced by lower doses of rUII (0.1 and 1 μM) in depolarized arteries with intact endothelium. This effect could facilitate arterial vasospasm in vascular pathophysiological processes such as subarachnoid hemorrhage and hypertension, when sustained depolarization and L-type Ca2+ channel activation are present.
Similar content being viewed by others
Abbreviations
- EDHF:
-
Endothelium-derived hyperpolarizing factor
- eNOS:
-
Endothelial nitric oxide synthase
- hUII:
-
Human urotensin II
- L-NAME:
-
Nω-nitro-L-arginine methyl ester
- LTCC:
-
L-type Ca2+ channel
- rUII:
-
Rat urotensin II
- UII:
-
Urotensin II
- UT:
-
Urotensin II receptor
- VSM:
-
Vascular smooth muscle
References
Abernethy DR, Schwartz JB (1999) Calcium-antagonist drugs. N Engl J Med 341:1447–1457
Adner M, Cantera L, Ehlert F, Nilsson L, Edvinsson L (1996) Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 119:1159–1166
Alexander SPH, Mathie A, Peters JA (2009) Guide to Receptors and Channels (GRAC) 4th edn. Br J Pharmacol 158:S1–S254
Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM et al (1999) Human urotensin II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282–286
Benham CD, Tsien RW (1987) A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle. Nature 328:275–278
Bottrill FE, Douglas SA, Hiley CR, White R (2000) Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130:1865–1870
Cheung BM, Leung R, Man YB, Wong LY (2004) Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22:1341–1344
Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM et al (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 95:15803–15808
Do Rego JC, Leprince J, Scalbert E, Vaudry H, Costentin J (2008) Behavioral actions of urotensin-II. Peptides 29:838–844
Douglas SA, Sulpizio AC, Piercy V, Sarau HM, Ames RS, Aiyar NV, Ohlstein EH, Willette RN (2000) Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131:1262–1274
Fernández-Tenorio M, Porras-González C, Castellano A, del Valle-Rodríguez A, López-Barneo J, Ureña J (2011) Metabotropic regulation of RhoA/Rho associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction. Circ Res 108:348–357
Harder DR, Dernbach P, Waters A (1987) Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 80:875–880
Ishihata A, Sakai M, Katano Y (2006) Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide. Peptides 27:80–86
Kobayashi S, Kanaide H, Nakamura M (1986) Complete overlap of caffeine- and K+ depolarization sensitive intracellular calcium storage site in cultured rat arterial smooth muscle cells. J Biol Chem 261:15709–15713
Koide M, Nystoriak MA, Brayden JE, Wellman GC (2011) Impact of subarachnoid hemorrhage on local and global calcium signaling in cerebral artery myocytes. Acta Neurochir Suppl 110:145–150
Liu JC, Chen CH, Chen JJ, Cheng TH (2009) Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Mol Pharmacol 76:1186–1195
Mayhan WG (1992) Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res 29:353–358
Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS, Bern HA (1980) Urotensin II: a somatostatin like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A 77:5021–5024
Pozzan T, Rizzuto R, Volpe P, Meldolesi J (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74:595–636
Quaile MP, Kubo H, Kimbrough CL, Douglas SA, Margulies KB (2009) Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium. Circ Heart Fail 2:39–46
Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746–752
Rossowski WJ, Cheng BL, Taylor JE, Datta R, Coy DH (2002) Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 438:159–170
Sima B, Weir BK, Macdonald RL, Zhang H (1997) Extracellular nucleotide-induced [Ca2+]i elevation in rat basilar smooth muscle cells. Stroke 28:2053–2058
Simard JM, Li X, Tewari K (1998) Increase in functional Ca2+ channels in cerebral smooth muscle with renal hypertension. Circ Res 82:1330–1337
Waldron GJ, Garland CJ (1994) Contribution of both nitric oxide and a change in membrane potential to acetylcholine-induced relaxation in the rat small mesenteric artery. Br J Pharmacol 112:831–836
Watanabe T, Takahashi K, Kanome T, Hongo S, Miyazaki A, Koba S et al (2006) Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Hypertens Res 29:821–831
Zhang AY, Chen YF, Zhang DX, Yi FX, Qi J, Andrade-Gordon P et al (2003) Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol Renal Physiol 285:F792–F798
Ziltener P, Mueller G, Haening B, Scherz MW, Nayler O (2002) Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines. J Recept Signal T Transduct Res 22:155–168
Acknowledgments
This study is fully supported by grant 10/02044 from Instituto de Salud Carlos III (Spanish National Health System). We thank Dr. Antonio Ordoñez for his assistance in this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Porras-González, C., Ureña, J., Egea-Guerrero, J.J. et al. Contractile responses to rat urotensin II in resting and depolarized basilar arteries. J Physiol Biochem 70, 193–199 (2014). https://doi.org/10.1007/s13105-013-0293-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-013-0293-0